business

Travere Therapeutics stock hits 52-week high at 48.7 USD

Investing.com · Jun 9, 2026, 1:55 PM · Also reported by 3 other sources

Read full story on Investing.com → More top stories

Also covered by

The Hindu High gold prices hit jewellery manufacturers as they pay tax for the gold stock with them Yahoo Finance SpaceX Stock Starts Trading This Week. Here's What to Expect. Yahoo Finance Is Enovis Corporation (ENOV) a High-Growth, Under-Valued Stock?

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Travere Therapeutics stock hits 52-week high at 48.7 USD

Also covered by

More in business